Lexicon Announces Publication Of TELESTAR Study Results For Telotristat Ethyl In The Journal Of Clinical Oncology
Go back to Lexicon Announces Publication Of TELESTAR Study Results For Telotristat Ethyl In The Journal Of Clinical Oncology| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.25 -0.02 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $19.62 | |||
| Open | $2.28 | 52 Week Low | $7.65 | |||
| Day High | $2.28 | P/E | N/A | |||
| Day Low | $2.21 | EPS | $-0.22 | |||
| Volume | 1,465,319 | |||||
